NG BIOTECH
Created in 2012
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
400 5,425Activities
Technologies
Entity types
Location
ZI Courbouton, 35480 Guipry-Messac, France
Guipry-Messac
France
Employees
Scale: 51-200
Estimated: 58
SIREN
752130831Engaged corporates
10
5 5Added in Motherbase
4 years, 5 months ago
deeptech Value proposition
Rapid, mobile, connected diagnostics
At NG Biotech, we develop, manufacture and commercialise rapid, mobile and connected diagnostics to modernize diagnosis practice worldwide.
NG Biotech is a French company specialized in Research & Development, Manufacturing and Marketing of a new generation of "multiplex", "quantitative" and "connected" rapid diagnostics for biomarker analysis and/or therapy monitoring at the Point of Care. NG Biotech’s patented platform is rapid, mobile and connected. It allows to simultaneously analyse up to 9 biomarkers from a biological direct sample such as a single finger-prick drop of blood. The results can be sent via smartphone within five minutes.
NG Biotech commercializes a range of rapid diagnostic devices covering antimicrobial resistance, women’s health and infectious disease.
NG Biotech also proposes custom development partnerships with further manufacturing to support breakthrough innovative ideas with rapid diagnostic needs. Backed by a strong R&D team and 30 years of know-how, NG-Biotech is always at the hedge of technology and can conduct projects from feasibility stage up to CE marking and FDA clearance.
m-Health, e-Health, AMR, IVD, Diagnostics, OTC, antimicrobialresistance, womenhealth, and point of careOriginal language
Rapid, mobile, connected diagnostics
At NG Biotech, we develop, manufacture and commercialise rapid, mobile and connected diagnostics to modernize diagnosis practice worldwide.
NG Biotech is a French company specialized in Research & Development, Manufacturing and Marketing of a new generation of "multiplex", "quantitative" and "connected" rapid diagnostics for biomarker analysis and/or therapy monitoring at the Point of Care. NG Biotech’s patented platform is rapid, mobile and connected. It allows to simultaneously analyse up to 9 biomarkers from a biological direct sample such as a single finger-prick drop of blood. The results can be sent via smartphone within five minutes.
NG Biotech commercializes a range of rapid diagnostic devices covering antimicrobial resistance, women’s health and infectious disease.
NG Biotech also proposes custom development partnerships with further manufacturing to support breakthrough innovative ideas with rapid diagnostic needs. Backed by a strong R&D team and 30 years of know-how, NG-Biotech is always at the hedge of technology and can conduct projects from feasibility stage up to CE marking and FDA clearance.
Home Page - NG Biotech
https://www.ngbiotech.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Réseau Entreprendre Startup accelerator & VC | Réseau Entreprendre Startup accelerator & VC | Other 7 Oct 2022 | | |
 | Gouvernement | Other 26 Nov 2023 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 20 Jun 2024 | | |
 Caisse d’Epargne Banking | Caisse d’Epargne Banking | Other 27 Jan 2021 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 22 Jul 2021 26 Nov 2023 | | |
 Pôle EMC2 Public business cluster, French Cluster, Civic and Social Organizations | Pôle EMC2 Public business cluster, French Cluster, Civic and Social Organizations | Other 7 Oct 2022 | | |
 Ouest-France Media, Newspaper Publishing | Ouest-France Media, Newspaper Publishing | Other 1 Jul 2023 | | |
 Le Journal des Entreprises Media, Newspaper Publishing | Le Journal des Entreprises Media, Newspaper Publishing | Other 29 Aug 2022 | | |
 Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 7 Jun 2024 | | |
 CEA Research | CEA Research | Other 26 Nov 2023 | | |